BioSpace News Archive

Catalent, Inc. announced that Wetteny Joseph, Senior Vice President & Chief Financial Officer, will present at the 9th Annual SVB Leerink Global Healthcare Conference at 10:00 a.m. ET on Tuesday, February 25, 2020 in New York City.

Hologic, Inc. announced that the Company will present at these upcoming investor conferences

Synthetic biology company taking major steps in worldwide effort to put a stop to the SARS-CoV-2 outbreak, including co-funding purchases of BioXp™ 3200 System.

Gilead Sciences, Inc. announced that Johanna Mercier, Chief Commercial Officer, and Merdad Parsey, MD, PhD, Chief Medical Officer, will participate in a fireside chat at the Cowen and Company 40th Annual Health Care Conference in Boston on Monday, March 2 at 12:00 p.m. Eastern Time.

Clinical Ink, a global clinical trial technology company, announces the addition of a new component to their Lumenis™ eSource Ecosystem

Endologix, Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that Vaseem Mahboob, Chief Financial Officer, will present at the 9th Annual SVB Leerink Global Healthcare Conference at 3:00 p.m. ET on Wednesday, February 26, 2020 in New York, NY.

Pandion Therapeutics, a privately-held biotechnology company developing modular protein therapeutics for autoimmune disease, today announced that company management will present at the SVB Leerink 9th Annual Global Healthcare Conference on Tuesday, February 25, 2020 at 1:30 p.m. ET in New York, NY.

Stryker, one of the world’s leading medical technology companies, announced it has been named one of Fortune’s 2020 100 Best Companies to Work For in its annual survey and evaluation of top-rated workplaces in the United States for a 10th consecutive year.

BioVentrix, Inc., a pioneer of technologies and procedures for the less invasive treatment of heart failure (HF), today announced that Gregg Stone, MD, of New York’s Mount Sinai Health System has signed on to the pivotal ALIVE Trial of the Revivent TC™ TransCatheter Ventricular Enhancement System as co-principal investigator.

Henry Schein, Inc. (Nasdaq:HSIC), today announced its lineup of new solutions and product offerings for the 2020 Chicago Midwinter (CMW) Dental Meeting, taking place February 20-22, 2020.